Steven Brandon Thorpe

Title: The Innovations of Steven Brandon Thorpe

Introduction

Steven Brandon Thorpe is an accomplished inventor based in Palmyra, Virginia. He has made significant contributions to the field of biochemistry, particularly in the development of sphingosine kinase inhibitors. With a total of 2 patents to his name, Thorpe's work has the potential to impact the treatment of various diseases.

Latest Patents

Thorpe's latest patents focus on sphingosine kinase inhibitor amidoxime prodrugs. Sphingosine kinases are enzymes that catalyze the biosynthesis of sphingosine-1-phosphate. His inventions provide prodrugs of compounds that effectively inhibit sphingosine kinase type 1, sphingosine kinase type 2, or both. These compounds, described by formula (I), are useful in treating a range of diseases where increasing the level of sphingosine-1-phosphate in the blood is medically indicated. Additionally, the inventions include pharmaceutical compositions of these formula (I) compounds.

Career Highlights

Throughout his career, Thorpe has worked with notable organizations such as the University of Virginia Patent Foundation and Virginia Tech Intellectual Properties Inc. His experience in these institutions has allowed him to further his research and development in the field of biochemistry.

Collaborations

Some of Thorpe's notable coworkers include Webster L. Santos and Kevin R. Lynch. Their collaborative efforts have contributed to the advancement of research in sphingosine kinase inhibitors.

Conclusion

Steven Brandon Thorpe's innovative work in the field of biochemistry, particularly with sphingosine kinase inhibitors, showcases his dedication to advancing medical treatments. His contributions through patents and collaborations highlight the importance of innovation in addressing health challenges.